Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2006-06-13
2006-06-13
Wax, Robert A. (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S101000
Reexamination Certificate
active
07060466
ABSTRACT:
The present invention relates to a nucleic acid segment having a coding region segment encoding enzymatically activeStreptococcus equisimilishyaluronate synthase (seHAS), and to the use of this nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product. Hyaluronate is also known as hyaluronic acid or hyaluronan.
REFERENCES:
patent: 4224179 (1980-09-01), Schneider
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4511478 (1985-04-01), Nowinski et al.
patent: 4517295 (1985-05-01), Bracke et al.
patent: 4708861 (1987-11-01), Popescu et al.
patent: 4780414 (1988-10-01), Nimrod et al.
patent: 4782046 (1988-11-01), Brown et al.
patent: 4784990 (1988-11-01), Nimrod et al.
patent: 4801539 (1989-01-01), Akasaka et al.
patent: 5015577 (1991-05-01), Weigel et al.
patent: 5023175 (1991-06-01), Hosoya et al.
patent: 5071751 (1991-12-01), Morita et al.
patent: 5948900 (1999-09-01), Yother et al.
patent: RE37336 (2001-08-01), Weigel et al.
patent: 6423514 (2002-07-01), Briskin
patent: 0036776 (1988-05-01), None
patent: 0195303 (1989-11-01), None
patent: 0144019 (1990-06-01), None
patent: 0265578 (1993-07-01), None
patent: 0244757 (1994-11-01), None
patent: 2249315 (1992-05-01), None
patent: 62032893 (1987-02-01), None
patent: 63094988 (1988-04-01), None
patent: 02193818 (1992-03-01), None
patent: 4-158796 (1992-06-01), None
patent: 91/03559 (1991-03-01), None
patent: 94/00463 (1994-01-01), None
patent: 95/24497 (1995-09-01), None
patent: 97/20061 (1997-06-01), None
“The Biosynthesis of Hyaluronic Acid ByStreptococcus,” Stoolmiller, et al., Journal of Biological Chemistry, vol. 244, No. 2, pp. 236-246 (1969).
“Modern Genetics,” Ayala, et al. Benjamin/Cummings Publishing Col., Menlo Park CA, p. 45 (1980).
“Strains ofEscherichia coliCarrying the Structural Gene for Histidyl-tRNA Synthetase on a High Copy-Number Plasmid,” Eisenbeis, et al., Mol. Gen. Genet. 183:115-122 (1981).
“Synthesis of Hyaluronate in Differentiated Teratocarcinoma Cells,” Prehm et al., J. Biochem, vol. 211, pp. 191-198 (1983).
“Isolation, Structure and Expression of Mammalian Genes for Histidyl-tRNA Synthetase,” Tsui, et al., Nucleic Acids Research, vol. 15, No. 8, pp. 3349-3367, (1987).
“Shuttle Vectors Containing a Multiple Cloning Site and a Lacza Gena for Conjugal Transfer of DNA fromEscherichia colito Gram-Positive Bacteria,” Trieu-Cout, et al., Gene, vol. 102, pp. 99-104, (1991).
“Analysis of TEH Streptococcal Hyaluronic Acid Synthase Complex Using the Photoaffinity Probe 5-Azido-UDP-Glucuronic Acid,” Van de Rijn, et al., J. Biol., Chem., vol. 267, No. 34, pp. 24302-24306, (1992).
“Molecular Characterization of a Locus Required for Hyaluronic Acid Capsule Production in Group AStreptococci,” Dougherty, et al., J. Exp. Med., vol. 175, pp. 1291-1299, (1992).
“HYALURONAN,” Laurent, et al., FASEB Journal, vol. 6, pp. 2397-2404, (1992).
“Isolation of aStreptococcus pyogenesGene Locus That Directs Hyaluronan Biosynthesis in Acapsular Mutants and in Heterologous Bacteria,” DeAngelis, et al., J. Biol. Chem., vol. 268, No. 20, pp. 14568-14571, (1993).
“Hyaluronate Synthase: Cloning and Sequencing of the Gene fromStreptococcusSP.,” Lansing, et al., J. Biochem., vol. 289, pp. 179-184, (1993).
“Molecular Characterization of HASB from an Operon Required for Hyaluronic Acid Synthesis in Group AStreptococci,” Dougherty, et al., J. Biol. Chem., vol. 268, No. 10, pp. 7118-7121, (1993).
“Molecular Cloning, Identification, and Sequence of the Hyaluronan Synthase Gene from Group AStreptococcusPyogenes,” DeAngelis, et al., J. Biol. Chem., vol. 268, No. 26, pp. 19181-19184, (1993).
“Molecular Characterization of HASA from an Operon Required for Hyaluronic Acid Synthesis in Group AStreptococci,” Dougherty, et al., J. Biol. Chem., vol. 269, No. 1, pp. 169-175, (1994).
“TheStreptococcusPyogenes Hyaluronan Sytnhase: Sequence Comparison and Conservation Among Various Group A Strains,” DeAngelis, et al., Biochem. and Biophy. Res. Comm., vol. 199, No. 1, pp. 1-10, (1994).
“The Production of Capsules, Hyaluronic Acid and Hyaluronidase by Group A and Group CStreptococci”, MacLennan, J. Gen. Microbiol., 14:134-142 (1956).
“The Isolation and Characterization of a Hyaluronidase Produced by a Capsulated Strain of Group CStreptococcus”, MacLennan, J. Gen. Microbiol., 14:143-152 (1956).
“The Biosynthesis of Hyaluronic Acid by Group AStreptococcus”, Markovitz et al., J. Biol. Chem., 234 (9):2343-2350 (1959).
“Biosynthesis of Hyaluronic Acid byStreptococcus”, Sugahara et al., J. Biol. Chem., 254:6252-6261 (1979).
“Streptococcal Hyaluronic Acid: Proposed Mechanisms of Degradation and Loss of Synthesis During Stationary Phase”, Van de Rijn, J. Bacteriol., 156(3): 1059-1065 (1983).
“Solubilization of Hyaluronic Acid Synthetic Activity FromStreptococciand its Activation with Phospholipids”, Triscott et al., J. Biol. Chem., 261 (13):6004-6009 (1986).
“Isolation of Streptococcal Hyaluronate Synthase”, Prehm et al., Biochem. J., 235:887-889 (1986).
“Streptococcal Hyaluronic Acid; Proposed Mechanisms of Degradation and Loss of Synthesis During Stationary Phase”, Van de Rijn, J. Bacteriol., 156(3):1059-1065 (1983).
“Homologs of the Xenopus Developmental Gene DG42 are Present in Zebrafish and Mouse and are Involved in the Synthesis of Nod-Like Chitin Oligosaccharides During Early Embryogenesis”, Semino et al., Proc. Natl Acad. Sci. USA, 93:4548-4553 (1996).
“Enzymological Characterization of the Pasteurella Multocida Hyaluronic Acid Synthase”, DeAngelis, Biochemistry, 35 (30): 9768-9771 (1996).
“Molecular Cloning, Expression, and Characterization of the Authentic Hyaluronan Synthase from Group CStreptococcus equisimilis”, Kumari and Weigel, J. Biol. Chem., 272(51): 32539-32546 (1997).
“Hyaluronan Synthases”, Weigel et al., J. Bil. Chem., 272 (22): 13997-14000 (1997).
“Identification and Molecular Cloning of a Unique Hyaluronan Synthase from Pasteurella Multocida”, DeAngelis et al., J. Biol. Chem., 273(14): 8454-8458 (1998).
“The Role of the Mucoid Polysaccharide (Hyaluronic Acid) in the Virulence of Group A HemolyticStreptococci”, Kass et al., J. Of Exp. Med., 79:319-330 (1944).
“The Biology of Hyaluronan”, Evered and Whelan Eds., CIBA Foundation Symposium 143 (1989).
“Hyaluronic Acid Capsule is a Virulence Factor for Mucoid Group AStreptococci”, Wessels et al., Microbiology, 88:8317-8321 (1991).
“New Frontiers in Medical Sciences: Redefining Hyaluronan”, Abatangelo and Weigel Eds., (2000).
DeAngelis Paul L.
Kumari Kshama
Weigel Paul H.
Dunlap Codding & Rogers P.C.
The Board of Regents of the University of Oklahoma
Wax Robert A.
LandOfFree
Methods of producing hyaluronic acid using a recombinant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of producing hyaluronic acid using a recombinant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of producing hyaluronic acid using a recombinant... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3621536